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I. Toward the Total Synthesis of Maoecrystal V 
The diterpenoid maoecrystal V (I) was discovered in the Chinese medical herb, Isodon 
eriocalyx. In comparison to related natural products, its molecular skeleton has been highly 
modified by bond-breaking and rearrangements, rendering access through total synthesis 
highly attractive (Figure I). 
 
Figure I. Molecular structure of maoecrystal V, originating from an ent-kaurane 
 
Synthetic efforts toward the dense architecture of the target molecule are described, based 
on a strategy employing small electrophiles and nucleophiles. The central elements of the 
synthesis comprise the formation of the central [2.2.2]bicyclooctanone by an intramolecular 
aldol addition, a stereoselective introduction of a C1 equivalent to form alkyne V as well as 
a double alkylation of lactone VI in the proximity of tetrasubstituted carbon atoms. The 
developed robust synthesis has led to advanced precursor VIII to the natural product 
(Scheme I). 
 













































II. Total Synthesis of Sandresolide B and Toward the Total Synthesis of Caribenol A 
Sandresolide B (XIV) and caribenol A (XVIII) both were found in the soft coral, Pseudo-
pterogorgia elisabethae that was collected in Caribbean Sea waters. Close structural 
resemblance of their carbon skeletons prompted the investigation of a common synthetic 
approach, which is described herein.  
Following stereoselective Myers alkylation of advanced furan intermediate X as well as a 
later Friedel–Crafts acylation of XII, the implementation of developed biomimetic 
oxidation conditions led to the total synthesis of sandresolide B (XIV, Scheme II).  
 
Scheme II. Total synthesis of sandresolide B 
 
For caribenol A (XVIII), initially a strategy based on precursor XV prepared analogously 
to sandresolide B (XIV) was examined (Scheme III). The formation of the required five-
membered ring via a carbenium ion which is intramolecularly trapped by the exo double 
bond of the side chain did not proceed, but led to elimination product XIX. 
 





















































































A revised approach has been elaborated, proceeding through auxiliary-controlled alkylation 
of enol ether XX and Stork–Danheiser reaction to yield cyclopentenone XXII. Eventually, 
the efficient construction of the carbon skeleton XXIII of caribenol A (XVIII) was ac-
complished via Friedel–Crafts triflation of XXII and verified by x-ray crystallographic 
measurements (Scheme IV). 
 


















































III. Total Synthesis of the Proposed Structure of Trichodermatide A 
Trichodermatide A (XXIX), an unprecedented polyketide, was isolated together with three 
further congeners from the marine-derived fungus, Trichoderma reseii. The synthesis of the 
published structure was approached via a highly symmetrical intermediate XXVIII that was 
formed by a Knoevenagel condensation/Michael addition cascade as well as stereoselective 
bis(α-hydroxylation). Conditions were developed to realize the isomerization of the 
symmetrical intermediate XXVIII to yield the reported structure of trichodermatide A 
(XXIX). X-ray crystallography confirmed the connectivity of the synthesized molecule 
(Scheme V). 
 
Scheme V. Total synthesis of the proposed structure of Trichodermatide A 
 
The NMR spectra of the synthesized material did not match those published for the natural 
product. We conclude that trichodermatide A is an isomer of the reported structure, as 

























































Throughout human history, plants and their extracts have been instrumental in medicinal 
applications.1 Most of the efficacy is ascribed to the presence of secondary metabolites 
rather than other constituents commonly found in all types of organisms: building blocks, 
energy sources, enzymes, structural materials or hereditary elements.2 Taking into account 
the metabolic cost for the biosynthesis of secondary metabolites, it is considered likely that 
plants produce these natural products to obtain an advantage when facing environmental 
challenges.2,3 Particularly, secondary metabolites assist in the survival of the plant facing 
threats from herbivores, pathogens, other plants, and radical damage or even simply lack of 
nutrients. Previous research found that many secondary metabolites have a very specific 
effect in other organisms and often show high complementarity to enzyme receptors.4  
 
Hence, it is not surprising, that natural products find use in modern medicine and continue 
to be part of various therapies. Considering the period 1981–2014 alone, 51% of newly 
approved drugs were either natural products, their derivatives, mimics or molecules 
containing natural product pharmacophores.5 The role as privileged scaffolds stems from 
the high structural diversity obtained via selective evolution according to their biological 
resources.2 To explore further potential therapies, research programs directed into isolation 
and characterization of natural products aim at uncovering new substances. Selected 
examples will be discussed in the individual chapters of the thesis. 
 
 
2. Isolation and Structure 
With the isolation of over 1,000 ent-kauranoids, including over 700 new ones, the group of 
Prof. Han-Dong Sun at the Kunming Botanical Institute has contributed to research in 
identification of chemical substances from the Isodon genus of plants.6 These plants are rich 
in terpenoids and their extracts have been used as traditional medicine for a long time,7,8 
hence raising the interest in this species and its natural product constituents.9  
 
In 1994, upon search for bioactive compounds, 5 mg of maoecrystal V (1) were isolated 
from 11.9 kg of dried powdered leaves from Isodon eriocalyx (Dunn.) Hara. The structure 
was tentatively established based on extensive analysis of MS, IR and NMR data. These 
results were not published, as the isolationists sought to verify the tentative structure, which 
 4 
would have implied an unprecedented rearrangement of the ent-kaurane carbon framework. 
Eventually, after a single crystal could be obtained, the unusual structure of maoecrystal V 
(1) could be confirmed by x-ray analysis and disclosed in 2004.10  
 
Figure 1.1. Molecular and x-ray structure of maoecrystal V 
 
The absolute configuration was postulated based on closely related natural products that 
were previously isolated from the same botanical origin, where the relative configuration 
had been determined. Maoecrystal V (1) originates from an ent-kaurane structure, exhibiting 
a highly modified skeletal and oxidation pattern. The most distinct features include a 
[2.2.2]bicyclooctanone and a strained cyclic ether, all embedded within a system of five 
interwoven rings. The rings comprise a spirocyclic δ-lactone as well as a trans-fused 
cyclohexenone, which add to the compact framework. Moreover, the close proximity of 
three adjacent quaternary stereocenters makes maoecrystal V (1) a challenging target for 
total synthesis.   
 
 
3. Maoecrystal Natural Products Family 
To understand the remarkable position of maoecrystal V (1) among its congeners, the family 
of this natural product should be considered. The maoecrystal molecules are members of 
the ent-kaurane diterpenoids11 originating from I. eriocalyx. As representatives of an 
important genus of the Labiatae (=Lamiaceae) family,8 Isodon species have been the source 
of 11 groups of diterpenoids to date.12 The members of the maoecrystal family can be 
assigned to four groups, classified by the oxidation and skeletal patterns. The first and 
largest category are the mono-7,20-epoxy-ent-kauranes, a subgroup of the C20-oxygenated-
ent-kauranes: maoecrystal B–G (2–7),13,14 I–K (8–10),15,16 epi-maoecrystal P (11),17 
maoecrystal Q–T (12–15),18,19 maoecrystal X (16) and Y (17).20 Although the ent-kaurane 
carbon skeleton is intact, this group features an oxymethine at C20 forming an epoxy ring 








Figure 1.2. Structures of mono-7,20-epoxy-ent-kauranes, maoecrystal B–G, I and J 
 
Maoecrystal I (8) and J (9) stand out in terms of their biological activities as both have been 
found to inhibit the root growth of lettuce seedlings. This effect was hypothetically 
attributed to the α-methylene group conjugated to a carbonyl group, acting as a Michael 
acceptor for the addition of a thiol-containing enzyme.15 Furthermore, maoecrystal I (8) 
exhibited inhibition of the Wnt signaling pathway, as well as selective cytotoxicity toward 
the colon carcinoma cell lines SW480, HCT116 and HT29.21 
 
 











































































































































Three maoecrystal molecules are part of mono-3,20-epoxy-ent-kauranes, the second 
subgroup of C20-oxygenated ent-kauranes: maoecrystal A (18),13 U (19)17 and P (20)22. 
Similar to the class of mono-7,20-epoxy-ent-kauranes, the positions C6, C7 and C15 are 
oxygenated. Differentiating structural features include a ketone group at C1 and C15, as 
well as oxygenation at C3.  
 
 
Figure 1.4. Structures of mono-3,20-epoxy-ent-kauranes maoecrystal A, U and P 
 
These natural products are believed to arise from 7,20-epoxy-ent-kauranoids containing an 
α,β-unsaturated ketone group, where an intramolecular Michael addition takes place at C3.8 
Evidence to support this biosynthetic assumption have been provided by Sun and co-
workers, who converted maoecrystal B (2) into neorabdosin (21) in the presence of 
Ac2OBF3 and obtained maoecrystal A (18) when exposing maoecrystal B (2) to HCl.13 
 
 
Scheme 1.1. Conversion of maoecrystal B into neorabdosin and maoecrystal A 
 
With respect to bioactivity, maoecrystal P (20) showed significant cytotoxicity against 
human tumor T24 cells, a characteristic that is presumably due to the presence of the α,β-



















































Another sizeable structural type is represented by the 6,7-seco-ent-kauranes. In this group, 
the C6–C7 bond has been oxidatively cleaved to provide spirolactone (7,20-lactone)-type 
natural products. The aldehyde that is anticipated to form at C6 during the biosynthesis, is 
present in maoecrystal L (22), or is further oxidized to a carboxyl group, as in maoecrystal N 
(23), epi-N (25), O (24) and W (26).20,23 All members of this family feature a substructure 
composed of four rings and a ketone at C15 as well as a reduced olefin group at C16/C17. 
 
 
Figure 1.5. Structures of 6,7-seco-ent-kauranes, maoecrystal L, N, O epi-N and W 
 
Maoecrystal M (27),24 categorized into the class of ent-kauranoid dimers, bears a 
symmetrical structure, which is unique among dimers isolated from the genus Isodon. A 
[2+2]-cycloaddition reaction involving the exocyclic double bonds at C16/C17 has 
presumably afforded the unusual four-membered ring.8  
 
 
Figure 1.6. Structure of the ent-kauranoid dimer, maoecrystal M 
 
The fourth structural class of the maoecrystal family, miscellaneous ent-kauranoids, 
encompasses those members that cannot easily be integrated into any of the other 
categories.8 During biosynthesis, the carbon skeletons of both maoecrystal V (1)10 and 



























































natural products currently only accessible by total synthesis. Regarding maoecrystal Z (28), 
considerable cytotoxicity has been observed against human tumor cell lines K562, MCF7, 
A2780 with IC50 values of 2.90 µg/mL, 1.63 µg/mL, 1.45 µg/mL, respectively.7 Noteworthy 




Figure 1.7. Structure of the miscellaneous ent-kauranoid, maoecrystal Z 
 
Maoecrystal V (1) is referred to in the literature as the most modified naturally occurring 
ent-kauranoid from the genus Isodon, emphasizing its extraordinary status within the 
maoecrystal family. The unprecedented 6,7-seco-6-nor-15(8→9)-abeo-5,8-epoxy-ent-
kaurene backbone includes only 19 carbon atoms, one carbon atom being lost during the 
biosynthesis of this diterpenoid.10 
 
 
Figure 1.8. Structures and labelling of maoecrystal V 
 
 
4. Biosynthetic Hypothesis 
Sun and co-workers formulated a hypothesis on the biosynthetic pathway toward 
maoecrystal V (1), starting from prevailing 7,20-epoxy-ent-kaurane 29.7 In the initial step, 
oxidative cleavage of the C6–C7 bond would lead to spirolactone 30. The aldehyde group 
would undergo further oxidation to carboxylic acid 31. An additional cleavage of the C8–
C15 bond would afford intermediate 32. Subsequent decarboxylation in the presence of 















































The bioactivity of maoecrystal V (1) was assessed in vitro with respect to cytotoxicity. 
Among the four human tumor cell lines K562, A549, BGC-823 and HeLa evaluated in the 
assay, low IC50 values of 0.02 µg/mL were obtained toward HeLa cells. The cytotoxic effect 
was observed at significantly lower concentrations than for the standard treatment cis-platin 
(IC50 of 0.99 µg/mL). Toward the other four cell lines investigated, very high IC50 values 
were measured (Table 1.1).10 Therefore, maoecrystal V (1) can be regarded as non-cytotoxic 
toward those cell lines, indicating a highly selective activity profile. 
 
 IC50 (µg/mL) 
test substance K562 A549 BGC-823 HeLa 
maoecrystal V (1) 6.43 ´ 104 2.63 ´ 105 1.47 ´ 104 0.02 
cis-platin 0.38 1.61 0.25 0.99 




















































6. Review of Total Syntheses of Maoecrystal V 
Maoecrystal V (1) displaying potent activity combined with low toxicity and a chemically 
interesting structure caused high interest in the development of a total synthesis, particularly 
as only small amounts were available from its natural source. In addition to our 
contributions to this research problem in 2010,25 numerous approaches toward the target 
have been published,26-37 with five research groups succeeding in completion of the total 
synthesis.38-44 Four of these syntheses proceeded via a Diels–Alder strategy to address the 
challenge of constructing the [2.2.2]bicyclooctanone ring element. Here, only completed 
total syntheses are discussed. 
 
In 2012, Danishefsky accomplished the total synthesis of maoecrystal V (1) utilizing an 
intramolecular Diels–Alder reaction (IMDA) strategy for expedient access to the frame-
work.38 Starting from commercially available 34, IMDA substrate 36 was synthesized, 
which upon heating underwent cycloaddition and elimination of phenylsulfinate, furnishing 
maoecrystal V core 37 including [2.2.2]bicyclooctane and lactone motifs (Scheme 1.3). 
Further modification by chemoselective epoxidation, oxirane opening and directed 
epoxidation gave rise to molecule 38. In a key step, epoxide 38 underwent cyclization upon 
treatment with p-TsOH to furnish the tetrahydrofuranoid ring, albeit forming a cis junction 
with the cyclohexene. To obtain the correct connectivity for maoecrystal V (1), 
epimerization of the C5 stereocenter was effected by a series of transformations. Exo-glycal 
41 was synthesized and subjected to DMDO and BF3OEt2 initiating epoxidation followed 
by rearrangement to form compound 42 with the desired trans ring junction. Having the 
core system set-up, the synthesis of maoecrystal V (1) was completed by installation of the 
gem-dimethyl unsaturated ketone functionality on the cyclohexane ring as well as the ketone 
and α-methyl group of the [2.2.2]bicyclooctane. In summary, the synthesis of maoecrystal V 
(1) proceeded via an IMDA as key step to obtain four of the five rings present in the target 
molecule. Although the tetrahydrofuranoid was formed with the undesired ring fusion, a 




Scheme 1.3. Danishefsky group’s total synthesis of maoecrystal V 
 
In 2014, the Thomson group reported an enantioselective synthesis of maoecrystal V (1) 
based on a Diels–Alder approach to form the key [2.2.2]bicyclooctane motif.39 This 
transformation was carried out at an advanced stage of the synthesis, as late installation of 
the THF ring with the bicyclooctane already in place proved challenging in previous studies. 
The first key step in the synthesis was a diastereoselective formation of the spirocenter at 
C10 by Heck reaction of precursor 44, which in turn could be obtained from dimethyl-
cyclohexenone 43 (Scheme 1.4). Subjection of TES-protected 44 to Pd(PPh3)4 and penta-
methylpiperidine (PMP) followed by TBAF yielded two alkene isomers, the major product 
45 carrying a double bond in the 2,3-position. Interestingly, only isomer 45 could undergo 
oxidative cyclodearomatization, forming the required tetrahydrofuran ring upon treatment 
with PhI(OAc)2. Under the same reaction conditions, oxidation of the minor isomer 46 was 
observed. Completion of the maoecrystal V (1) backbone was achieved by generating enol 
ether 49, which was reacted with nitroethylene in a Diels–Alder cycloaddition yielding 
[2.2.2]bicyclooctane 50 as a single diastereomer. Adjustment of functionalities of the 
carbocyclic core led to maoecrystal V (1) in six further steps, including two late-stage C–H 
oxidations. As in initial investigations, α-methylation of a C15 ketone formed a mixture of 
inseparable epimers, Thomson and co-workers chose to prepare exo-enone 51. Reduction 










































34 35 36 37
38 39 40
41 42 maoecrystal V (1)
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Scheme 1.4. Thomson group’s total synthesis of maoecrystal V 
 
The first total synthesis of maoecrystal V (1) was accomplished in 2010 by Yang and co-
workers, who built up the intertwined ring system of the target molecule through IMDA of 
an elegantly designed precursor.40,41 To construct the quaternary center at C10, β-ketoester 
53, available from ketone 52, was subjected to an oxidative arylation with lead compound 
54 (Scheme 1.5). The envisioned reduction to cis-diol 56 could be implemented stepwise 
by first obtaining the desired C5 alcohol by reaction with Bu4NBH4, then reducing the ester 
with LiAlH4. Esterification of the primary alcohol and treatment with TsN3 furnished 
diazophosphate 57. In a key step, 57 underwent O–H bond insertion to give phosphonate 
ester 58, which could be transformed into enone 59 by Horner–Wadsworth–Emmons 
reaction with paraformaldehyde, followed by MOM deprotection. Enone 59 set the stage 
for oxidative dearomatization in the presence of Pb(OAc)4 to diastereomeric hydroquinone 
acetates, which readily underwent IMDA to furnish [2.2.2]bicyclooctane, lactone and 
tetrahydrofurane functionalities of the target molecule in one transformation. Although the 
cycloaddition was facially unselective, desired product 60 could be isolated in 36% yield. 
















































alkene, and oxidation resulted in the C16 epimer of maoecrystal V (1). Equilibration of 
misconfigured stereocenter in epi-maoecrystal V with DBU led to a 1:1 mixture of epimers, 
from which maoecrystal V (1) could be isolated, thus completing a concise synthesis.  
 
 
Scheme 1.5. Yang group’s total synthesis of maoecrystal V 
 
In 2014, Zakarian and co-workers successfully addressed two major challenges: formation 
of the [2.2.2]bicyclooctanone and installation of the strained furan.42,43 As an enantio-
determining step, early installation of the furan by Rh-catalyzed C–H insertion was 
envisioned. After initial attempts by means of chiral catalyst systems, modification with 
chiral auxiliaries achieved the desired results. The synthesis started from sesamol (61), 
which was transformed into diazo compound 62 (Scheme 1.6). Pyrrolamides of mandelic 
acid were found to be effective in controlling diastereoselectivity in the C–H insertion and, 
in the presence of Rh(II) acetate, furan 63 was formed with 84% ee. Full epimerization of 
C10 was achieved by methanolysis, which also led to cleavage of the amide. The quaternary 
stereocenter was installed by reacting a zinc enolate, generated from ester 64, with benzyl 
chloromethyl ether. Constructing the [2.2.2]bicyclooctanone unit was carried out through 
an IMDA, where the dienophile was an ethylene equivalent tethered to the molecule. The 
required substrate was prepared by PhI(O2CCF3)2 oxidation of the phenol obtained after 
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56 57 58
59 60 maoecrystal V (1)
O
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cycloaddition delivered the required key structural element in 96% yield. The silyl tether 
and both ethoxy groups were removed by subsequent transformations. Installation of the 
required lactone was envisioned to be effected by radical cyclization: the required seleno-
carbonate 68 was formed and subjected to (TMS)3SiH/AIBN, where radical cyclization 
proved successful to obtain the anticipated lactone 69. Completion of the synthesis included 
diastereoselective methylation of the bicyclooctanone and installation of the cyclo-
hexenone. The optical rotation values were in accordance with the measurements published 
by the isolationists, confirming the assigned absolute configuration. 
 
 
Scheme 1.6. Zakarian group’s total synthesis of maoecrystal V 
 
In contrast to previously published total syntheses of maoecrystal V (1), in 2016, Baran and 
co-workers reported their second-generation approach to establish the [2.2.2]bicyclooctane 
framework through a pinacol-type rearrangement, analogous to the proposed biosynthetic 
route.44 Allylsilane 71, accessed from cyclohexenone (70), underwent a Baldwin-disfavored 
cyclization uniquely in the presence of EtAlCl2, a large number of Lewis acids being 









































































key precursor 73. Addition of dimethylcyclohexenone fragment 74, which contributes all 
of the carbon atoms for the maoecrystal V A ring, could be achieved by using the corre-
sponding Grignard reagent. At this stage, intermediate 75 was subjected to aqueous TsOH 
and the remarkable 1,2-shift led to the desired [2.2.2]bicyclooctanone, while simultaneously 
the methylene double bond isomerized into the endocyclic position. Installation of the final 
quarternary center could be realized chemoselectively by the addition of LaCl32LiCl to the 
1,4-sodium enolate of 76, favoring aldol reaction with formaldehyde at the sterically 
hindered C10 position. Subsequent modifications allowed selective reduction of the C5 
ketone to afford alcohol 78. Treatment of compound 78 with CH(OMe)3/MeOH and 
methanesulfonic acid formed the furanoid ring, which reacted with ZnI2 and TMSCN to 
introduce the final carbon atom. The lactone ring was formed under hydrolytic conditions, 
furnishing the natural product’s backbone. To complete the synthesis, an oxidation/iodina-
tion sequence installed the required oxidation and unsaturation patterns.  
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The synthetic maoecrystal V (1) was subjected to cytotoxicity screenings against various 
cancer cell lines, but showed no significant activity against any cell line, including HeLa.44 
These observations support the finding that a cytotoxic mode of action is observed in 
compounds carrying an enone with exomethylene.9  
 
The accomplished syntheses not only provided enough material for more thorough 
biological testing, but would also open up avenues for the synthesis of potentially more 
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7.1. Toward the Total Synthesis of Maoecrystal V: Establishment of 
Contiguous Quaternary Stereocenters 
 
Reprinted with permission from 
I. Baitinger, P. Mayer, D. Trauner, Org. Lett. 2010, 12, 5656–5659. 
 
Copyright© 2010 American Chemical Society. 
 
 
Within the published results, work in the context of the thesis comprises the elaboration 
















































































































































































II. Total Synthesis of Sandresolide B and 













1. Introduction and Background 
Natural products from marine sources display a vast structural diversity, generated by the 
rich variety of source organisms in their respective habitats.1 One remarkable source of such 
natural products is the Pseudopterogorgia species of the gorgonians, which are the most 
common octocorals in the Caribbean Sea.2 While P. americana is the most widespread 
among the 15 known species, P. elisabethae has received the strongest interest from natural 
product researchers due to the high variety of diterpenoids encountered in this invertebrate. 
Accounting for more than 20 diterpenoid skeletal variants found over the past 40 years (as 
exemplified in Figure 2.1),3-5 P. elisabethae demonstrates its biosynthetic capability to form 
diverse structural variants from basic starting materials.  
 
 
Figure 2.1. Terpenoid carbon skeletons originating from Pseudopterogorgia elisabethae3-5 
serrulatane amphilectane norseco-amphilectane trisnorseco-amphilectane
tetrisnor-amphilectane elisabethane seco-elisabethane norseco-elisabethane
bisnorseco-elisabethane pentanorseco-elisabethane elisapterane elisabane
 78 
 
Figure 2.1. (cont.) Terpenoid carbon skeletons originating from Pseudopterogorgia 
elisabethae3-5 
 
The natural products of relevance to the work described here, sandresolide B6 (81) and 
caribenol A7 (82), are shown in Figure 2.2. One of the distinguishing features of these 
natural products is their ring systems comprising a hydroxybutenolide moiety. This moiety 
is synthetically accessible from furans, and we were intrigued to use a furan-based strategy 
for the total syntheses of these two molecules. Moreover, the close structural resemblance 
of the carbon backbones indicated that a common synthetic approach could potentially be 
applied to both natural products.  
 
colombiane cumbiane seco-cumbiane ileabethane





Figure 2.2. Structures of sandresolide B and caribenol A 
 
 
2. Isolation and Structure 
The group of Abimael D. Rodríguez in Puerto Rico has intensively explored novel structures 
of natural products from P. elisabethae. Although the primary focus was to uncover 
structurally novel metabolites, the researchers also evaluated biological activity of the 
newly-discovered natural products in the areas of inflammation, infectious diseases and 
cancer.  
 
During an underwater expedition in the Eastern Caribbean Sea in 1996, Rodríguez and co-
workers collected a specimen of P. elisabethae near San Andrés Island, Columbia. When 
reexamining the extracts of a 1.0 kg dry weight sample, the group discovered sandresolide B 
(81) (Figure 2.3), an investigation they  published in 1999.6 The structural assignment was 
established by a combination of extensive 1D and 2D NMR experiments, along with IR, 
UV and HRMS analyses. The distinctively unique structure of the novel norditerpene 
features a network of a seven-carbon ring joined to a six-membered ring, both of which are 
fused to a 5-hydroxyfuranone. In total, sandresolide B (81) contains six stereocenters as 
well as an unsaturated isobutenyl side chain. 
 
 
Figure 2.3. Structure and carbon ring nomenclature (amphilectane based) of sandresolide B 
 
As part of a campaign in 2002, Rodríguez and co-workers examined the chemotype of a P. 
elisabethae specimen collected near Old Providence Island in the proximity of Nicaragua. 
From the hexane-soluble part of the gorgonian extract, which was subjected to a series of 



























purification steps, 9.0 mg of caribenol A (82) could be isolated.7 The structure of the 
molecule was derived from the comprehensive analysis of 2D NMR experiments. X-ray 
diffraction studies confirmed the structure and determined the relative configuration (Figure 
2.4).  
 
Figure 2.4. Structure and carbon ring nomenclature (amphilectane based) of caribenol A 
 
Caribenol A (82) comprises a polycyclic core, with three adjacent all-carbon rings forming 
a 5,7,6-tricarbocyclic skeleton. As in sandresolide B (81), an additional lactone hemiketal 




3. Biosynthetic Considerations 
Rodríguez and co-workers have postulated a biosynthetic pathway illustrating plausible 
interconnections between the frameworks of sandresolide B (81) and caribenol A (82).7 
Catechol 83 can be regarded as the common starting point for further skeletal modifications 
toward both natural products. This polycyclic structure is known as both C1 epimers and 
has been confirmed as a direct biosynthetic precursor of the anti-inflammatory 
pseudopterosins using radiolabeling studies.8 
 
Rodríguez proposes that the biosynthesis starts with an oxidation to form o-quinone 84, 
followed by further skeletal modifications yielding cyclopentadienone 85 (Scheme 2.1). 
This intermediate initially undergoes hydration and tautomerizes to dienol 86. Its polycyclic 
structure is likely the precursor to the unique carbon skeleton embedding a seven-membered 
ring. The key transformation is triggered by oxidative cleavage of the enol, resulting in 
hydroxyketone 87 which undergoes an α-ketol rearrangement giving 88. The overall 
degradation and rearrangement sequence leads to the expansion of ring C to a seven-
membered ring. Reduction of the ketone at C5 allows the condensation to the respective 












OH and C5-H being on the same face. The congener sandresolide B (81) arises from 
oxidation at C5. Caribenol A (82) is potentially obtained from 89 by oxidation at C5 and a 
C14–C4 cyclization in several steps. 
 
 
Scheme 2.1. Proposed biosynthesis of sandresolide B and caribenol A 
 
 
4. Biological Properties of Sandresolide B and Caribenol A 
Gorgonian corals have very few predators9 – a striking observation considering the 
abundance of these soft corals as well as the high predation intensity of their habitats.10,11 
To date, no definite explanation of the reasons behind this observation exists. Multiple 
research activities have not reached a definitive conclusion on the role of sclerites in animal 
tissue as a means of physical defense, or the sufficiency of nutritional value for feeding 
purposes. Interestingly, it was demonstrated via fish feeding assays that the addition of 
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deterred consumption.12 Consequently, organic compounds have been commonly regarded 
as the primary defense instrument of these species. Additional evidence points toward the 
function of secondary metabolites to inhibit settlement of larvae, to aid in resistance to fungi, 
as well as to deter overgrowth by other organisms.13-15  
 
As a result, natural products originating from the gorgonians have received considerable 
interest with regard to their pharmacological profiles, and potent biological activities 
associated with these natural products have been identified, as summarized in a review by 
Kerr.16 Many natural products from the P. elisabethae family have been demonstrated to 
possess anti-tuberculosis activity. Accordingly, newly isolated metabolites are commonly 
evaluated against Mycobacterium tuberculosis.17 For sandresolide B (81), however, no 
screening of biological activity has been reported. On the other hand, caribenol A (82) has 
been evaluated for inhibitory activity against M. tuberculosis H37Rv, demonstrating a MIC 
value of >128 µg/mL. It was also found to possess weak in vitro antiplasmodial activity 
against chloroquine-resistant malaria parasite Plasmodium falciparum W2 with an IC50 
value of 20 µg/mL.7 
 
 
5. Previous Synthetic Efforts toward Caribenol A 
The attractive combination of novel molecular architectures together with potentially useful 
pharmacological activities of sandresolide B (81) and caribenol A (82) have motivated 
numerous research laboratories to explore chemical syntheses of these scarce substances. 
 
Other than our contributions, total syntheses have not been reported for either sandres–
olide B (81), or other members of its family.18 For caribenol A (82), in addition to the 
synthesis published by our group,19 two groups have succeeded in the chemical syntheses 
of the target molecule. In the following section, the key transformations of completed total 
syntheses will be discussed. 
 
The approach by Yang and co-workers was designed to expediently construct the tricyclic 
carbon skeleton of caribenol A (82) in order to provide a model route to further molecular 
variants.20 An intramolecular Diels–Alder reaction (IMDA) was planned as a key step in 
the total synthesis. By selecting favorable starting materials, two of the six stereocenters 
required for the target molecule could already be incorporated during the opening sequence.  
 83 
 
Scheme 2.2. Yang group’s total synthesis of caribenol A 
 
In an initial step, iodide 91, after treatment with t-BuLi was added to enone 90 to yield 
intermediate 92 after oxidative rearrangement (Scheme 2.2). Subsequent transformations 
were aimed at installing an activated alkyne for the reaction with the electron-rich diene as 
well as converting the carbonyl group of an enone into silyl ether 93. The key IMDA 
reaction could be effected by addition of BHT in catalytic amounts to form the tricyclic core 
94 of caribenol A (82). As a result of the selected geometry of the diene scaffold 93, two 
further stereocenters were generated as required. Subsequent chemoselective 
hydrogenation, reduction and esterification reactions yielded furan-2-one 95, which could 
be transformed into intermediate 96 upon oxidation and hydrogenation. Completion of the 
carbon backbone 97 was achieved by Pd-catalyzed coupling of ZnMe2 to the previously 
generated enol triflate. Biomimetic and stereoselective installation of the hydroxyl group at 
C5 could be successfully performed through oxidation with molecular oxygen in the 
presence of a base and P(OEt)3, leading to caribenol A (82). The authors stated that with a 
successful synthesis route established, their goal was the creation of a library based on the 
natural product to allow for further medicinal analysis and structure-activity investigation. 
 
More recently, the group of Luo succeeded in the synthesis of caribenol A (82) in the context 
of a campaign to develop a general synthetic route to serrulatane- and amphilectane-based 
natural products.21 The starting material 98 was prepared by 1,4-addition of a methyl group 



































































(Scheme 2.3). The outcome of the addition was controlled by a chiral ligand and the 
installed stereocenter acted as a template to govern the stereocenters formed later in the 
synthesis. Substrate 100, prepared by alkylation of β-ketoester 98, was transformed into 
lactone 101 in a four-step sequence to set up the precursor for the first key step. Upon 
heating to 200 °C under microwave conditions, precursor 101 underwent a thermal Cope 
rearrangement to furnish 102. The desired relative stereochemical outcome of the newly 
formed stereocenters was thereby controlled by the cis-geometry of the pendant alkene in 
the substrate.  
 
 
Scheme 2.3. Luo group’s total synthesis of caribenol A 
 
After formation of the furan moiety as well as extension of the side chain to a total of eight 
carbon atoms, intermediate 103 was subjected to the second key transformation of the 
synthesis. In a gold-mediated closure of the seven-membered carbon ring, the nucleophilic 
furan added intramolecularly to the Au(III)-activated enone with good diastereoselectivity. 
Completion of the carbon backbone was achieved by reaction with diazo(trimethylsilyl)-
methyllithium, and C-H insertion of the resulting carbene to yield cyclopentene 105, which 
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6.1. Synthetic Studies toward Caribenol A 
6.1.1. Initial Synthetic Approach 
In the initial retrosynthetic analysis, the characteristic hydroxybutenolide moiety of 
caribenol A (82) was traced back to furan 105 through oxidation (Scheme 2.4). Further 
disconnections follow the proposed biosynthetic pathway and include the addition of a 
methyl and an alkene group onto a carbonyl group within intermediate 106. The C4 carbonyl 
is instrumental for a Friedel–Crafts acylation to form the C4–C5 bond. The seven-
membered ring is further dissected at C2/C3 through an asymmetric Myers’ alkylation1 as 
employed by us in the synthesis of sandresolide B (81).2 Corresponding starting materials 
include iodide 108, previously constructed by our group in the total synthesis of 
sandresolide B (81),2 as well as amide 107.  
 
 
Scheme 2.4. Initial retrosynthetic analysis of caribenol A 
 
Based on the experience previously gathered for the alkylation of β-branched alkyl iodide 
108,2 pseudoephedrine was selected as a suitable chiral auxiliary. Thus, (–)-pseudo-
ephedrine was N-acylated with literature known acid 1093 (Scheme 2.5). The reaction 
proceeded via activation of the carboxylic acid 109 as the mixed anhydride, which reacted 
smoothly with (–)-pseudoephedrine to form amide 107. After deprotonation of 107 with 
LDA to the corresponding lithium enolate, reaction with iodide 108 yielded alkylation 
product 110. Adding LiCl to the reaction is crucial to allow for stereoselective conversion 









































face of the enolate. Additionally, O-alkylation at the auxiliary’s hydroxyl group is sup-
pressed.4 To cleave off the auxiliary, a standard protocol was employed, involving t-butyl 
ammonium hydroxide formed in situ from n-butyl ammonium hydroxide and the t-butyl 
alcohol.4 This reagent allowed to avoid epimerization of the newly-formed stereocenter. 
Carboxylic acid 111 was subjected to intramolecular Friedel–Crafts acylation with the furan 
as the nucleophile. Due to the presence of trifluoroacetic anhydride and excess zinc chloride 
rapid conversion to the desired furyl ketone 106 was achieved. 
 
 
Scheme 2.5. Preparation of the key intermediate 106 
 
Having synthesized the key intermediate 106, the completion of the carbon skeleton by 
formation of the final cyclopentene ring was examined. According to our initial strategy, 
formation of a tertiary alcohol by addition of a methyl group to the ketone was required. In 
the event, using excess methyl lithium in combination with short reaction times - the 
conditions that have proved effective during optimization of sandresolide B (81) synthesis 
- successfully led to tertiary alcohol 112 (Scheme 2.6). Although full characterization was 
not carried out with this unstable compound, good stereoselectivity was observed as 
confirmed by NOE experiments. It was rationalized that exposure of this tertiary alcohol to 







































could be intramolecularly trapped by the exo double bond of the side chain, forming the 
required five-membered ring. Thus, several acidic conditions were screened, including DL-
camphorsulfonic acid, p-toluenesulfonic acid and pyridinium p-toluenesulfonate, as well as 
heating of the reaction mixtures. In all cases, strong coloration of the reaction mixture was 
observed, whereby upon quenching only the thermodynamic elimination product 113, 
which presents the newly-formed double bond in conjugation to the furan, could be obtained 
(Scheme 2.6). Presumably, the position of the formed positive charge relative to the furan 
rendered a highly stable carbenium ion, thus disfavoring nucleophilic attack by the side-
chain double bond.  
 
 
Scheme 2.6. Attempted construction of caribenol A carbon backbone 
 
At this stage, possible workarounds such as already transforming the furan into the 
butenolide to suppress the stabilizing effect of the furan on the carbenium ion were not 
considered feasible. Firstly, competing side reactions with the butenolide during methyl 
additions would be expected. Additionally, the experiences gained with the furan system 
indicated that the cyclization to the cyclopentene ring does not advance easily despite the 
intramolecular nature of this reaction. Consequently, a revised strategy was designed to 
ensure the five-membered ring is in place early in the reaction sequence. 
 
 
6.1.2. Revised Approach toward Caribenol A 
Upon revision, the retrosynthetic analysis retains the oxidation of the furan in intermediate 
105 as a late step (Scheme 2.7). Further disconnections include a Negishi cross-coupling to 
install the alkenyl methyl group via an enol intermediate obtainable from the ketone moiety 
within intermediate 114. The seven-membered ring was envisioned to be connected by 
means of a Michael addition between a cyclopentenone and an electron-rich furan. Working 
backwards, the cyclopentenone with the suitable 3,4-substitution pattern would be obtained 
through a Stork–Danheiser reaction5 of the alkoxy-substituted 1,3-cyclopentadione 117. 

















(<50% over 2 steps)
106 112 113
 90 
in an asymmetric alkylation to form the C2–C3 bond. In summary, the target molecule can 
be traced back retrosynthetically to the precursors 108 and 115. 
 
 
Scheme 2.7. Revised retrosynthetic analysis of caribenol A 
 
To execute the proposed synthesis, the literature-known intermediate 115 was prepared by 
condensation of (–)-menthol with 1,3-cyclopentanedione (116)6 (Scheme 2.8). Upon re-
examining previous work toward caribenol A (82) conducted in our group using (+)-
menthol,7 the (–)-stereoisomer of the auxiliary was selected to achieve the required R-
configuration outcome of the subsequent alkylation reaction. Enone 115 was treated with 
LDA to form the respective lithium enolate followed by diethyl zinc and readily displaced 
the iodide in 108 with good overall yield. It was key to perform the reaction under 
concentrated conditions to overcome the steric hindrance of the reactive site at the iodide 
and drive the reaction forward. Addition of diethyl zinc is assumed to lead to the formation 
of lithium alkoxydiethylzincate and was necessary to avoid self-coupling,8 considering that 
a nine-fold excess of the nucleophile was employed. Upon separation of the obtained 
mixture of diastereomers by preparative HPLC, the desired isomer 117 could be isolated in 
only 20% yield, along with 50% of its epimer, 118. This selectivity is most likely a result 
of the steric hindrance caused by the methyl group in the β-position, overriding the steric 
influence imposed by the relatively more distant menthol group. The outcome was even 
further shifted toward the undesired epimer when probing the reaction with (+)-menthol as 
the auxiliary. Optimization of the chiral auxiliary appended to the enone substrate should 





























































Scheme 2.8. Asymmetric alkylation of iodide precursor 108 
 
Despite the low yield of the alkylation reaction, sufficient quantities of 117 were accessible 
to continue examining the proposed total synthesis. Epimer 118 was carried along as a 
model system, allowing for screening of reaction conditions. Subjecting vinylogous ester 
118 to methyllithium resulted in clean conversion through a Stork–Danheiser reaction to 
the respective cyclopentenone 119 (Scheme 2.9).  
 
 
Scheme 2.9. Stork–Danheiser reaction to cyclopentenone 119  
 
The devised completion of the target molecule’s carbon skeleton required intramolecular 
conjugate addition of the furan onto the enone, a transformation that could be achieved by 
activation of the Michael system. However, initial attempts to conduct this transformation 
in the presence of Brønsted acids with different pKa values (such as camphorsulfonic acid, 
formic acid) or Lewis acids (such as BF3) failed. Fortunately, promising results were 















































Scheme 2.10. AuCl3-mediated intramolecular addition of the furan onto the Michael system 
 
Nevertheless, while the ring closure could be initiated, it was not possible to drive the 
reaction to satisfactory levels of conversion. The desired 7-membered ring containing 
product 120 could be obtained in low yields which varied between 33 and 44%. 
Interestingly, small amounts of diastereomer 114 were also formed with yields up to 11% 
during this reaction, indicating epimerization of the stereocenter at the cyclopentenone. In 
the attempt to drive the reaction to completion, further Lewis acid equivalents were added 
sequentially over the course of days, but considerable amounts of starting material remained 
unreacted. On the other hand, elevating the reaction temperature to 40°C resulted in 
decomposition of the substrate within less than an hour. These results seemed to confirm 
the enone’s anticipated poor reactivity due to substitution at the 4-position.  
 
Eventually, the problematic step could be overcome using Friedel–Crafts triflation 
conditions developed in our group for robust 1,4-addition involving sterically hindered 
systems.9 Treating enone 119 with 2,6-di-tert-butylpyridine followed by triflic anhydride 
smoothly afforded the tetracyclic intermediate 120 upon hydrolysis to the ketone by 
aqueous sodium hydroxide (Scheme 2.11). The structure of diastereomer 120 has been 
verified by NOESY experiments. It carries the fused seven-membered ring cis to the 























































When the optimized conditions were applied to the correct diastereomer, the reaction 
sequence of Stork–Danheiser reaction, Friedel–Crafts triflation and hydrolysis led to the 
desired ketone 114 in good yields (Scheme 2.12). 
 
 
Scheme 2.12. Constructing the tetracyclic framework 114 of caribenol A 
 
The structure of the crystalline product 114 was confirmed by single-crystal x-ray 
diffraction experiment. The resulting structure (Figure 2.5) shows that while the rings B and 
C as well as the furan form a flat, sheet-like structure, the cyclopentanone rises above this 
plane. The structure confirms that all the stereocenters are in place and in accordance with 





























Figure 2.5. X-ray structure of tetracycle 114 
 
The remaining transformations required to complete the total synthesis included conversion 
of the cyclopentanone motif into a methyl-substituted cyclopentene, and oxidation of the 
furan. As before, reaction conditions were studied using the undesired diastereomer 120, 
which shows opposite configuration at C3 and C4, owing to material availability. A 
sterically hindered base was selected to abstract the more accessible proton of the substrate. 
Regioselective deprotonation of cyclopentanone 120 by KHMDS, and subjection of the 
resulting potassium enolate to Comins’ reagent,10 provided triflate 123, which was cross-
coupled with dimethyl zinc in the presence of tetrakis(triphenylphosphine)palladium(0)11 
(Scheme 2.13). The resulting Negishi cross-coupling allowed to obtain the required cyclo-
pentene 124 in 75% yield. 
 
 




























The stage was then set for probing the key oxidation sequence to obtain the hydroxy-
butenolide system of caribenol A (82). Unfortunately, applying biomimetic oxidation 
conditions which have reliably yielded hydroxybutenolides from the respective furan 
systems in late stages of total syntheses12 to furan 124 only resulted in decomposition of the 
material (Scheme 2.14).  
 
 
Scheme 2.14. Attempted furan oxidation using the test system 124 
 
Presumably, an ene reaction with the electron-rich double bond embedded into the 
cyclopentene was occurring during the attempted furan oxidation. Thus, for completion of 
the total synthesis, the issue of selectivity of furan oxidation would have to be overcome by 
altering the reaction sequence. Starting from the cyclopentanone compound 114, initial 
furan oxidation followed by installing the methyl substituent should proceed smoothly 
according to previous results (Scheme 2.15).11  
 
 
Scheme 2.15. Proposed route for completion of caribenol A 
 
The above hypothesis has been validated by the subsequent research in our group,13 leading 
to caribenol A (82). Moreover, in 2016, Luo and co-workers have identified conditions to 












































114 126 caribenol A (82)
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6.1.3. Experimental Section 
General Experimental Details  
Unless stated otherwise, all reactions were carried out in oven-dried or flame-dried 
glassware under a positive pressure of nitrogen or argon. Tetrahydrofuran (THF), and 
diethyl ether (Et2O) were distilled from sodium benzophenone ketyl. Diiosopropylamine 
was distilled from and stored over CaH2. n-Butyllithium (n-BuLi) was titrated with 
diphenylacetic acid prior to use. Lithium chloride (LiCl) was heated at 140 ºC under high 
vacuum for 16 h prior to use. Molecular sieves (MS) were activated at 200 ºC and cooled 
under inert atmosphere. Nitromethane was purchased from Acros and stored over 3 Å 
molecular sieves. All other solvents as well as starting materials and reagents were used as 
obtained from commercial sources without further purification.  
Flash column chromatography was performed employing silica gel 60 (40-60 µm) as the 
stationary phase and the analytical grade solvents indicated. Reactions and chromatography 
fractions were monitored by analytical thin layer chromatography (TLC) using Merck silica 
gel 60 F254 glass plates. The eluted plates were visualized using a 254 nm UV lamp and/or 
by treatment with potassium permanganate (KMnO4) or ceric ammonium molybdate 
(CAM) solution followed by heating. 
Proton (1H) and carbon (13C) nuclear magnetic resonance (NMR) spectra were recorded at 
25 °C on Varian VNMRS 300, VNMRS 400, INOVA 400 or VNMRS 600 spectrometers. 
Proton chemical shifts are expressed in parts per million (ppm, δ scale) and are calibrated 
using residual non-deuterated solvent as an internal reference. 1H NMR data are reported as 
follows: chemical shift (δ) (multiplicity, coupling constant(s) J (Hz), relative integral). 
Multiplicity is defined as: s=singlet; d=doublet; t=triplet; q=quartet; m=multiplet; br=broad, 
or combinations of the above. Where coincident coupling constants have been observed in 
the NMR spectrum, the apparent multiplicity of the proton resonance concerned is reported. 
Carbon chemical shifts are expressed in parts per million (ppm, δ scale) and are referenced 
to the carbon resonances of the solvent. All raw NMR data is available on request. Addi-
tional supporting spectra can be found in the NMR spectra section. 
Mass spectroscopy (MS) experiments were performed on a Thermo Finnigan MAT 95 
(electron ionization, EI) or on a Thermo Finnigan LTQ FT (electrospray ionization, ESI) 
instrument. 
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Infrared (IR) spectra were recorded on a Perkin Elmer Spectrum BX II (FTIR System) 
instrument equipped with an attenuated total reflection (ATR) measuring unit. IR data is 
reported as absorption frequency (cm-1).  
X-ray analysis measurements were performed on an α Oxford Diffraction Xcalibur 
diffractometer at 173 K using graphite monochromated Mo-Kα-radiation (λ = 0.71073 Å).  
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Experimental Procedures and Product Characterization 
Pseudoephedrine amide 107 
 
To a solution of 109 (1.42 g, 12.4 mmol) in MeCN (60 mL) was added triethylamine 
(4.14 mL, 3.02 g, 29.9 mmol) and the solution was left to stir for 10 min at room 
temperature. After cooling to 0 °C, pivaloyl chloride (1.83 mL, 1.79 g, 14.9 mmol) was 
added, and the suspension was diluted by addition of THF (12 mL). A solution of 
(−)-pseudoephedrine (2.05 g, 12.4 mmol) and triethylamine (1.72 mL, 1.26 g, 12.4 mmol) 
in THF (30 mL) was added quickly to the reaction mixture via cannula. The reaction mixture 
was left to come to 15 °C over 1.5 h, at which point H2O (15 mL) were added. Volatiles 
were removed in vacuo at 70 mbar and the residue was diluted by addition of 50 mL of 
0.5 M aqueous NaOH and 60 mL of 10% MeOH in CH2Cl2. The aqueous phase was 
separated and extracted with 10% MeOH in CH2Cl2 (3 ´ 60 mL). The combined organic 
phases were washed with 1 M aqueous NaOH (20 mL), dried over Na2SO4 and concentrated. 
The residue was purified by flash column chromatography (30% acetone/hexanes), to afford 
2.69 g (10.3 mmol, 83%) of 107 as a colorless oil and as a 2:1 mixture of rotamers. 
TLC: Rf = 0.24 (50% EtOAc/hexanes). 1H NMR (400 MHz, CDCl3): δ [ppm] = 7.38 – 7.10 
(m, 5H), 4.68 (s, 1H), 4.64 – 4.57 (m, 1H), 4.55 – 4.17 (m, 2.6H), 4.00 – 3.88 (m, 0.4H), 
2.87 – 2.72 (m, 3H), 2.52 – 2.17 (m, 4H), 1.69 (s, 3H), 1.05 – 0.90 (m, 3H). 13C NMR (101 
MHz, CDCl3): δ [ppm] (major rotamer) = 174.7, 144.8, 142.4, 128.3, 127.6, 126.5, 110.0, 
76.3, 58.3, 33.1, 32.6, 32.6, 22.7, 14.4. IR (film): nmax [cm-1] = 3376, 3071, 2968, 2934, 
1618, 1451, 1404. HRMS (ESI+): calcd for C16H24NO2 ([M+H]+) 262.1802, found 
















Myers alkylation product 110 
 
To a suspension of lithium chloride (1.43 g, 33.7 mmol) and diisopropylamine (0.92 mL, 
0.68 g, 6.51 mmol) in THF (10 mL) at −78 °C was added n-BuLi (1.6 M in hexanes, 
3.92 mL, 6.27 mmol) dropwise. The resulting reaction mixture was warmed to 0 °C for 
5 min, and then cooled back to −78 °C. A solution of amide 107 (0.82 g, 3.13 mmol) in THF 
(15 mL), cooled to 0 °C, was then added dropwise by cannula. The reaction mixture was 
stirred for 1 h at −78 °C, and was then warmed to 0 °C for 15 min, then to room temperature 
for 5 min. After cooling the reaction mixture back to 0 °C, a solution of iodide 108 (0.733 g, 
2.41 mmol) in THF (5 mL) was added dropwise. The mixture was warmed to room 
temperature and stirred for 16 hours, then quenched with a 1:1 mixture of sat. aqueous 
NH4Cl/H2O (30 mL), and extracted with EtOAc (3 ́  50 mL). The combined organic phased 
were dried over Na2SO4 then concentrated, and the resulting residue was purified by flash 
column chromatography (10 to 60% EtOAc/hexanes) to provide 0.756 g (1.73 mmol, 72%) 
110 as a yellow oil.  
TLC: Rf = 0.27 (30% EtOAc/hexanes). 1H NMR (300 MHz, CDCl3): δ [ppm] = 7.42 – 7.22 
(m, 5H), 7.17 (t, J = 1.6 Hz, 1H), 6.96 (t, J = 1.7 Hz, 1H), 4.82 – 4.75 (m, 1H), 4.74 – 4.68 
(m, 1H), 4.66 – 4.58 (m, 1H), 4.38 (s, 1H), 4.17 – 4.07 (m, 1H), 2.94 – 2.74 (m, 4H), 2.68 
– 2.47 (m, 2H), 2.46 – 2.32 (m, 1H), 2.15 – 2.06 (m, 1H), 1.97 – 1.87 (m, 1H), 1.85 – 1.64 
(m, 5H), 1.60 – 1.41 (m, 2H), 1.40 – 1.04 (m, 8H), 0.77 (d, J = 6.8 Hz, 3H).  13C NMR (75 
MHz, CDCl3): δ [ppm] = 178.3, 143.4, 142.6, 137.5, 137.2, 128.8, 128.4, 127.7, 126.4, 
124.9, 112.2, 76.4, 58.3, 40.6, 38.7, 37.1, 37.0, 34.3, 34.1, 33.0, 28.1, 23.6, 23.0, 21.2, 15.8, 
















To 110 (0.748 g, 1.71 mmol) were added t-BuOH (5 mL), aqueous tetra-n-butylammonium 
hydroxide solution (40% w/w, 5.55 g, 8.55 mmol) and water (15 mL), and the mixture was 
heated at reflux for 20 h. After cooling to room temperature, the resulting mixture was 
treated with 0.5 M aqueous NaOH (20 mL), then extracted with EtOAc (40 mL). The 
separated aqueous layer was again extracted with EtOAc (2 ´ 40 mL), then adjusted to 
pH = 1 by the addition of a 1 M aqueous HCl solution. The resulting solution was extracted 
with EtOAc (2 ´ 50 mL). The combined organic phases were washed with H2O (50 mL), 
dried over Na2SO4, and concentrated. The residue was purified by flash column 
chromatography (40% EtOAc/hexanes solution containing 1% AcOH) and the fractions 
containing product were washed with sat. aqueous NaHCO3, dried over Na2SO4 and 
concentrated to afford 326 mg (1.12 mmol, 66%) of 111 as a colorless oil.  
1H NMR (599 MHz, CDCl3): δ [ppm] = 7.17 (t, J = 1.6 Hz, 1H), 7.11 (t, J = 1.6 Hz, 1H), 
4.80 (s, 1H), 4.76 (s, 1H), 2.80 – 2.74 (m, 1H), 2.70 (tt, J = 8.8, 6.0 Hz, 1H), 2.60 – 2.53 
(m, 1H), 2.39 (dd, J = 14.2, 8.7 Hz, 1H), 2.19 (dd, J = 14.2, 5.9 Hz, 1H), 1.99 – 1.94 (m, 
1H), 1.90 (dtd, J = 12.4, 4.7, 2.3 Hz, 1H), 1.75 (s, 3H), 1.73 – 1.67 (m, 1H), 1.67 – 1.63 (m, 
1H), 1.58 (ddd, J = 13.7, 7.5, 5.8 Hz, 1H), 1.33 – 1.30 (m, 1H), 1.21 – 1.14 (m, 4H), 0.83 
(d, J = 6.9 Hz, 3H). 13C NMR (151 MHz, CDCl3): δ [ppm] = 180.6, 142.8, 137.4, 137.4, 
128.9, 125.0, 112.6, 40.9, 36.8, 36.5, 34.6, 33.0, 29.9, 28.1, 23.4, 22.5, 21.2, 15.6. IR (film): 
nmax [cm-1] = 2954, 2922, 2852, 1706, 1651, 1455. HRMS (EI): calcd for C18H26O3 ([M]+) 

















To a solution of 111 (260 mg, 0.895 mmol) in CH2Cl2 (150 mL) at 0 °C was added trifluoro-
acetic anhydride (0.174 mL, 263 mg, 1.25 mmol) via a Teflon cannula. After warming the 
reaction mixture to room temperature for 10 min, a solution of ZnCl2 (1 M in THF, 1.79 mL, 
1.79 mmol) was added dropwise. The reaction mixture was left to stir for 30 min at room 
temperature, then heated to 40 °C for 1 h, and quenched upon cooling to room temperature 
by addition of 1 M aqueous HCl (10 mL). The organic layer was separated and washed with 
sat. aqueous NaHCO3 (30 mL), water (30 mL), brine (30 mL), dried over Na2SO4 and 
concentrated. The residue was purified by flash column chromatography (10% 
EtOAc/hexanes) to afford 190 mg (0.701 mmol, 78%) of 106 as a colorless oil. 
TLC: Rf = 0.35 (20% EtOAc/hexanes). 1H NMR (599 MHz, CDCl3): δ [ppm] = 7.38 (d, J 
= 1.6 Hz, 1H), 4.84 (s, 1H), 4.73 (s, 1H), 2.73 – 2.58 (m, 3H), 2.41 (ddd, J = 11.2, 9.3, 5.7 
Hz, 1H), 2.22 (dddd, J = 12.5, 5.6, 4.4, 2.1 Hz, 1H), 2.10 (ddd, J = 13.8, 10.0, 0.8 Hz, 1H), 
1.96 (dtd, J = 13.0, 4.7, 2.1 Hz, 1H), 1.82 – 1.66 (m, 6H), 1.31 (tdd, J = 13.1, 11.2, 2.1 Hz, 
1H), 1.25 – 1.20 (m, 4H), 1.08 (d, J = 6.5 Hz, 3H). 13C NMR (151 MHz, CDCl3): δ [ppm] 
= 191.3, 147.9, 143.2, 141.8, 135.7, 130.3, 113.2, 44.2, 40.1, 38.7, 36.3, 35.6, 32.8, 29.7, 
27.9, 22.2, 20.9, 20.4. IR (film): nmax [cm-1] = 2931, 1738, 1672, 1366, 1216. HRMS (ESI+) 





A solution of 106 (10 mg, 36.7 µmol) in THF (4 mL) was cooled to −78 °C and 
methyllithium (1.6 M in Et2O, 92 µL, 147 µmol) was added dropwise. The reaction mixture 
was left to stir at −78 °C for 10 min, warmed to room temperature, then quenched by the 














10 mL), and the combined organic phases were washed with brine (10 mL), dried over 
Na2SO4 and concentrated. The residue was redissolved in 4 mL toluene, heated to 90 °C 
and a solution of D,L-camphorsulfonic acid (0.05 M in toluene, 0.73 mL, 36.7 µmol) was 
added. The reaction mixture was left to stir for 30 min at 90 °C, warmed to room 
temperature, and concentrated. The residue was filtered over a silica plug which was then 
rinsed with a 1:1 mixture of hexanes/Et2O (30 mL) to afford 113 as a minor by-product 
(colorless oil, <5 mg). 
TLC: Rf = 0.64 (10% EtOAc/hexanes). 1H NMR (400 MHz, C6D6): δ [ppm] = 7.05 (d, J = 
1.7 Hz, 1H), 4.83 (s, 1H), 4.81 (s, 1H), 2.95 (d, J = 15.4 Hz, 1H), 2.65 (d, J = 15.4 Hz, 1H), 
2.57 – 2.47 (m, 1H), 2.36 – 2.19 (m, 3H), 2.17 (s, 3H), 1.83 – 1.70 (m, 3H), 1.64 (s, 3H), 
1.12 (d, J = 6.7 Hz, 3H), 1.10 – 1.03 (m, 2H), 0.93 (d, J = 6.8 Hz, 3H). 13C NMR (101 MHz, 
C6D6): δ [ppm] = 150.2, 143.5, 135.1, 132.1, 129.3, 123.8, 122.4, 111.2, 45.1, 44.7, 42.2, 
37.9, 33.8, 30.5, 28.2, 22.7, 21.6, 20.6, 15.3. IR (film): nmax [cm-1] = 2959, 2928, 2872, 
1762, 1648, 1454. 
 
The desired product 112 could be characterized as a minor component: 
 
1H NMR (400 MHz, C6D6): δ [ppm] = 7.00 (d, J = 1.8 Hz, 1H), 4.84 (s, 1H), 4.77 (s, 1H), 
2.63 (dd, J = 13.4, 2.7 Hz, 1H), 2.47 – 2.38 (m, 1H), 2.33 (s, 1H), 2.14 (dd, J = 13.3, 11.0 
Hz, 1H), 2.09 – 1.97 (m, 2H), 1.94 – 1.85 (m, 2H), 1.75 – 1.58 (m, 5H), 1.54 – 1.45 (m, 
4H), 1.12 – 0.99 (m, 5H), 0.89 (d, J = 6.7 Hz, 3H). 13C NMR (101 MHz, C6D6): δ [ppm] = 
153.3, 145.0, 134.8, 129.4, 117.7, 112.6, 74.3, 42.4, 38.8, 37.4, 37.0, 34.8, 33.4, 30.8, 28.4, 
22.1, 21.0, 20.9. 
 
 












A solution of 1,3-cyclopentadione (116, 5.00 g, 50.9 mmol), (−)-menthol (9.06 g, 
58.0 mmol) and p-toluenesulfonic acid (1.04 g, 5.47 mmol) in benzene (150 mL) was 
refluxed at 120 °C for 8 h using a Dean-Stark adapter. The solution was cooled to room 
temperature, and washed with sat. aqueous NaHCO3 solution (50 mL). The aqueous phase 
was extracted with EtOAc (2 ´ 70 mL), and the combined organic phases were washed with 
brine (60 mL), dried over Na2SO4, and concentrated. The residue was purified by flash 
column chromatography (25% to 60% EtOAc/hexanes) to afford 4.85 g (20.5 mmol, 40%) 
of 115 as a colorless solid. 
TLC: Rf = 0.32 (25% EtOAc/hexanes). 1H NMR (400 MHz, C6D6): δ [ppm] = 5.36 (s, 1H), 
3.78 (td, J = 10.7, 4.3 Hz, 1H), 2.17 – 2.03 (m, 4H), 2.03 – 1.92 (m, 2H), 1.49 – 1.40 (m, 
2H), 1.38 – 1.29 (m, 1H), 1.23 – 1.09 (m, 1H), 0.90 – 0.79 (m, 5H), 0.78 (d, J = 6.5 Hz, 
3H), 0.69 (d, J = 7.0 Hz, 3H), 0.67 – 0.61 (m, 1H). 13C NMR (101 MHz, C6D6): δ [ppm] = 
203.5, 188.1, 104.6, 81.8, 47.7, 39.7, 34.4, 34.1, 31.1, 28.8, 26.7, 23.8, 22.2, 20.7, 16.9. IR 
(film): nmax [cm-1] = 2952, 2925, 2868, 1705, 1678, 1585. HRMS (EI): calcd for C15H24O2 
([M]+) 236.1776, found 236.1767. Optical Rotation: [α]D25 = –156° (c 2.50, CH2Cl2). 
 
 
Alkylation products 117 and 118 
 
To a solution of diisopropylamine (0.86 mL, 0.62 g, 6.12 mmol) in THF (6 mL) cooled to 
−78 °C was added n-BuLi (1.6 M in hexanes, 3.64 mL, 5.82 mmol) dropwise. The solution 
was warmed to 0 °C over a period of 20 min, then cooled back to −78 °C. Enone 115 
(1.17 g, 4.93 mmol) in THF (3 mL) was added dropwise, and the reaction mixture was 
stirred for 20 min at −78 °C, then Et2Zn (0.58 mL, 0.69 g, 5.62 mmol) was added dropwise. 
After 5 min, iodide 108 (0.15 g, 0.49 mmol) in THF (2 mL), followed by dry DMPU 
(2.97 mL, 3.16 g, 24.7 mmol) were added. The reaction mixture was warmed to room 
temperature and stirred for 20 h. EtOAc (30 mL) was added, and the ensuing mixture was 
washed with 1 M aqueous HCl (20 mL) then H2O (20 mL), and the combined aqueous 
phases were extracted with EtOAc (3 ´ 40 mL). The combined organic phases were washed 
















and concentrated. The residue was purified by flash column chromatography (10% 
acetone/hexanes), followed by HPLC (EtOAc/hexanes 10% to 18% v/v gradient elution) to 





TLC: Rf  = 0.39 (20% EtOAc/hexanes). 1H NMR (400 MHz, CH2Cl2): δ [ppm] = 7.18 (t, J 
= 1.6 Hz, 1H), 7.14 (t, J = 1.6 Hz, 1H), 5.25 (s, 1H), 3.99 (td, J = 10.7, 4.3 Hz, 1H), 2.82 
(ddd, J = 17.4, 7.2, 1.1 Hz, 1H), 2.78 – 2.70 (m, 1H), 2.63 – 2.46 (m, 2H), 2.31 (ddd, J = 
17.5, 3.0, 1.1 Hz, 1H), 2.17 – 2.07 (m, 2H), 2.06 – 1.94 (m, 2H), 1.91 (dtd, J = 12.3, 4.8, 
2.2 Hz, 1H), 1.84 – 1.76 (m, 1H), 1.76 – 1.65 (m, 2H), 1.55 – 1.46 (m, 2H), 1.37 – 1.25 (m, 
2H), 1.21 – 1.16 (m, 4H), 1.12 – 1.02 (m, 2H), 0.98 – 0.88 (m, 7H), 0.87 – 0.82 (m, 3H), 
0.78 (d, J = 7.0 Hz, 3H). 13C NMR (100 MHz, CD2Cl2): δ [ppm] = 208.6, 188.6, 137.7, 
137.6, 129.4, 125.6, 103.3, 82.7, 47.9, 43.7, 39.9, 37.0, 36.6, 36.4, 35.3, 34.6, 33.3, 31.7, 
28.4, 26.9, 24.1, 23.4, 22.1, 21.3, 20.7, 16.9, 16.0. IR (film): nmax [cm-1] = 2954, 2927, 2869, 
1675, 1581. HRMS (ESI+): calcd for C27H41O3 ([M+H]+) 413.3056, found 413.3049. 
Optical Rotation: [α]D25 = -67° (c 1.75, CH2Cl2). 
 
 
TLC: Rf = 0.38 (20% EtOAc/hexanes). 1H NMR (400 MHz, CD2Cl2): δ [ppm] = 7.18 (t, J 
= 1.6 Hz, 1H), 7.17 (t, J = 1.6 Hz, 1H), 5.24 (s, 1H), 3.99 (td, J = 10.7, 4.3 Hz, 1H), 2.73 
(ddd, J = 17.5, 7.3, 1.1 Hz, 1H), 2.70 – 2.64 (m, 1H), 2.62 – 2.46 (m, 2H), 2.31 (ddd, J = 
17.4, 3.0, 1.1 Hz, 1H), 2.17 – 2.11 (m, 1H), 2.05 – 1.83 (m, 4H), 1.83 – 1.75 (m, 1H), 1.75 
– 1.68 (m, 2H), 1.56 – 1.47 (m, 2H), 1.36 – 1.26 (m, 2H), 1.22 – 1.16 (m, 4H), 1.11 – 1.01 
(m, 2H), 0.96 – 0.89 (m, 7H), 0.89 – 0.85 (m, 3H), 0.78 (d, J = 7.0 Hz, 3H). 13C NMR (100 
















39.8, 38.8, 37.2, 36.0, 35.1, 34.6, 33.3, 31.7, 28.3, 26.8, 24.3, 24.0, 22.1, 21.3, 20.8, 16.9, 
14.6. IR (film): nmax [cm-1] = 2962, 2925, 2860, 1691, 1590. HRMS (ESI+): calcd for 






To a solution of 117 (10.3 mg, 25.0 µmol) in THF (1 mL) at −78 °C was added dropwise 
methyllithium (1.6 M in Et2O, 0.14 mL, 225 µmol) and the reaction mixture was stirred for 
1.5 h. The dry ice bath was removed, then 0.4 M aqueous NaHSO4 (0.6 mL) was added, and 
the resulting reaction mixture was left to stir for 5 min before being diluted with 30% 
Et2O/hexanes (10 mL). The organic phase was separated, then washed with H2O (5 mL), 
brine (5 mL), dried over Na2SO4 and concentrated. The residue was purified by flash 
column chromatography (20% EtOAc/hexanes) to afford 5 mg (18.4 µmol, 74%) of 
cyclopentenone 122 as a colorless oil. 
TLC: Rf = 0.21 (20% EtOAc/hexanes). 1H NMR (400 MHz, C6D6): δ [ppm] = 7.11 (t, J = 
1.6 Hz, 1H), 7.03 (t, J = 1.6 Hz, 1H), 5.80 – 5.76 (m, 1H), 2.46 – 2.32 (m, 2H), 2.25 (dd, J 
= 17.9, 6.6 Hz, 1H), 2.20 – 2.12 (m, 1H), 1.87 (dd, J = 17.9, 2.0 Hz, 1H), 1.68 – 1.62 (m, 
1H), 1.50 – 1.58 (m, 1H), 1.44 (t, J = 1.1 Hz, 3H), 1.40 – 1.31 (m, 2H), 1.16 – 1.00 (m, 5H), 
0.73 – 0.59 (m, 4H). 13C NMR (100 MHz, C6D6): δ [ppm] = 206.2, 179.5, 137.8, 137.7, 
131.0, 128.8, 124.5, 42.4, 41.9, 39.0, 38.3, 35.3, 33.2, 28.3, 24.7, 21.2, 16.7, 14.9. IR (film): 
nmax [cm-1] = 2955, 2923, 2851, 1692, 1619. HRMS (ESI): calcd for C18H25O2 ([M+H]+) 


















To a solution of 118 (84.2 mg, 204 µmol) in THF (4.5 mL) at −78 °C was added dropwise 
MeLi (1.6 M in Et2O, 1.02 mL, 1.63 mmol) and the reaction mixture was warmed to 0 °C 
over 3 h. After addition of 0.4 M aqueous NaHSO4 (6 mL), the reaction mixture left to stir 
for 5 min before dilution with 30% Et2O/hexanes (50 mL). The organic phase was 
separated, then washed with H2O (20 mL), brine (20 mL), dried over Na2SO4 and 
concentrated. The residue was purified by flash column chromatography (20% 
EtOAc/hexanes) to afford 42 mg (154 µmol, 76%) of cyclopentenone 119 as a colorless oil. 
TLC: Rf = 0.21 (20% EtOAc/hexanes). 1H NMR (400 MHz, C6D6): δ [ppm] = 7.13 (t, J = 
1.6 Hz, 1H), 7.01 (t, J = 1.6 Hz, 1H), 5.80 – 5.75 (m, 1H), 2.56 – 2.49 (m, 1H), 2.46 – 2.37 
(m, 1H), 2.26 (dd, J = 18.0, 6.6 Hz, 1H), 2.20 – 2.12 (m, 1H), 1.92 (dd, J = 18.0, 2.3, 1H), 
1.75 – 1.61 (m, 2H), 1.51 – 1.34 (m, 5H), 1.19 – 0.99 (m, 5H), 0.75 – 0.61 (m, 4H). 13C 
NMR (100 MHz, C6D6): δ [ppm] = 206.3, 179.5, 137.8, 137.6, 130.9, 128.8, 125.0, 42.2, 
42.1, 37.7, 35.1, 35.0, 33.2, 28.3, 23.1, 21.2, 16.8, 16.2. IR (film): nmax [cm-1] = 2956, 2925, 
2869, 1711, 1692, 1619. HRMS (EI+): calcd for C18H24O2 ([M]+) 272.1776, found 





To a solution of 122 (7 mg, 25.7 µmol) in MeCN (5 mL) at room temperature powdered 
3 Å molecular sieves (200 mg) were added, and the resulting suspension was left to stir for 
1 h. After cooling to −20 °C, di-tert-butylpyridine (9.8 µL, 43.7 µmol) was added, followed 
by dropwise addition of triflic anhydride (17.1 µL, 103 µmol). The reaction mixture was 
warmed to −10 °C over the course of 30 min, at which point sat. aqueous NaHCO3 (5 mL) 
























a pad of Celite™ that was subsequently rinsed with CH2Cl2 (20 mL). The emulsion was 
washed with brine (10 mL), dried over Na2SO4 and concentrated. Purification of the residue 
by flash column chromatography (2% EtOAc/hexanes) afforded 5 mg (12.4 µmol, 48%) of 
triflate 114a as a colorless oil along with 2 mg (7.34 µmol, 28%) of tetracycle 114 as a white 
solid. The triflate 114a was carried on to the hydrolysis step. 
To a solution of 114a (5 mg, 12.4 µmol) in dioxane (1.5 mL) at room temperature was 
added a solution of sat. aqueous NaOH in water (2% w/w, 1.5 mL) and the reaction mixture 
was left to stir for 1 h. After addition of water (20 mL), the resulting mixture was extracted 
with Et2O (3 ́  20 mL). The combined organic phases were washed with H2O (10 mL), brine 
(10 mL), dried over Na2SO4 and concentrated. Purification of the residue by flash column 
chromatography (10% EtOAc/hexanes) afforded 3 mg (11.0 µmol, 89%) of tetracycle 114 
as a white solid. Overall, 5 mg (18.4 µmol, 71%) of tetracycle 114 could be obtained starting 
from 122. 
TLC: Rf = 0.59 (20% EtOAc/hexanes). 1H NMR (600 MHz, C6D6): δ [ppm] = 6.91 (d, J = 
1.8 Hz, 1H), 3.38 (dt, J = 17.6, 1.2 Hz, 1H), 2.42 – 2.35 (m, 1H), 2.14 (dd, J = 17.9, 12.8 
Hz, 1H), 1.97 – 1.83 (m, 3H), 1.74 – 1.69 (m, 1H), 1.67 – 1.58 (m, 2H), 1.50 (ddd, J = 15.1, 
5.7, 2.1 Hz, 1H), 1.39 – 1.28 (m, 2H), 1.09 (s, 3H), 1.06 – 0.90 (m, 5H), 0.78 (d, J = 6.6 Hz, 
3H). 13C NMR (150 MHz, C6D6): δ [ppm] = 213.7, 152.0, 135.6, 129.3, 119.3, 52.0, 44.9, 
44.9, 41.7, 40.7, 37.1, 33.4, 32.4, 30.6, 28.6, 25.6, 21.3, 20.9. IR (film): nmax [cm-1] = 2953, 
2922, 2873, 1740. HRMS (ESI): calcd for C18H25O2 ([M+H]+) 273.1855, found 273.1848. 
Optical Rotation: [α]D25 = –33° (c 0.24, CH2Cl2). 
Crystallographic data for compound 114 has been deposited at the Cambridge Crystallo-






To a solution of 119 (15 mg, 55.1 µmol) in MeCN (5 mL) at room temperature powdered 









1 h. After cooling to −20 °C, di-tert-butylpyridine (21.0 µL, 93.6 µmol) was added, 
followed by dropwise addition of triflic anhydride (37.0 µL, 219 µmol). The reaction 
mixture was warmed to −10 °C over the course of 30 min, at which point sat. aqueous 
NaHCO3 (5 mL) was added. After warming to room temperature, the resulting mixture was 
filtered through a pad of Celite™ that was subsequently rinsed with CH2Cl2 (40 mL). The 
emulsion was washed with brine (10 mL), dried over Na2SO4 and concentrated. The residue 
was taken up in dioxane (2 mL), a solution of sat. aqueous NaOH in water (2% w/w, 1.5 mL) 
was added and the reaction mixture was left to stir for 1 h at room temperature. After 
addition of water (20 mL), the resulting mixture was extracted with EtOAc (3 ´ 30 mL). 
The combined organic phases were washed with H2O (20 mL), brine (20 mL), dried over 
Na2SO4 and concentrated. Purification of the residue by flash column chromatography (10% 
EtOAc/hexanes) afforded 8 mg (29.4 µmol, 53%) of tetracycle 120 as a colorless oil. 
TLC: Rf = 0.60 (20% EtOAc/hexanes). 1H NMR (600 MHz, C6D6): δ [ppm] = 6.98 (d, J = 
1.8 Hz, 1H), 2.49 – 2.38 (m, 2H), 2.38 – 2.34 (m, 1H), 2.20 (dq, J = 18.0, 1.2 Hz, 1H), 1.85 
– 1.74 (m, 3H), 1.73 – 1.64 (m, 2H), 1.31 (d, J = 0.8 Hz, 3H), 1.30 – 1.25 (m, 1H), 1.25 – 
1.16 (m, 2H), 1.10 – 1.01 (m, 4H), 0.99 – 0.94 (m, 1H), 0.79 (d, J = 6.7 Hz, 3H). 13C NMR 
(150 MHz, C6D6): δ [ppm] = 214.6, 152.9, 135.5, 129.7, 119.4, 50.2, 46.4, 45.1, 44.7, 43.4, 
42.5, 38.8, 33.6, 30.1, 28.3, 26.7, 21.4, 21.4. IR (film): nmax [cm-1] = 2954, 2917, 2868, 
1742. HRMS (EI+): calcd for C18H24O2 ([M]+) 272.1776, found 272.1771. Optical Rotation: 




To a solution of 119 (9 mg, 33.0 µmol) in MeCN (2 mL) was added AuCl3 (10 N in MeCN, 
0.1 ml, 1 mg, 3.30 µmol) and the solution was left to stir for 48 h at room temperature. The 
reaction mixture concentrated and the residue was purified by flash column chromatography 
(10% EtOAc/hexanes) to afford 4 mg (14.7 µmol, 44%) of 120 as a colorless oil along with 




















Enol triflate 123 
 
To a solution of 120 (18 mg, 66.1 µmol) in THF (7 mL) at −78 °C was added KHMDS 
(0.5 M in toluene, 0.145 mL, 72.7 µmol). After stirring at this temperature for 30 min, a 
solution of Comins’ reagent (29 mg, 72.7 µmol) in THF (2 mL) was added and the mixture 
was left to stir for 3 h at −78 °C. The reaction was treated with sat. aqueous NH4Cl (7 mL) 
and extracted with Et2O (3 ´ 20 mL). The combined organic phases were dried over 
Na2SO4, and concentrated. The residue was purified by flash column chromatography (2% 
EtOAc/hexanes) to afford 23 mg (56.9 µmol, 86%) of 123 (mixture of diastereomers) as a 
colorless oil. 
1H NMR (600 MHz, C6D6): δ [ppm] (major diastereomer) = 7.01 (d, J = 1.8 Hz, 1H), 5.14 
(td, J = 2.8, 1.0 Hz, 1H), 2.73 – 2.68 (m, 1H), 2.51 – 2.45 (m, 1H), 2.42 (dd, J = 16.1, 1.0 
Hz, 1H), 2.06 (dq, J = 11.4, 2.9 Hz, 1H), 1.77 – 1.84 (m, 2H), 1.76 – 1.71 (m, 1H), 1.43 (s, 
3H), 1.32 – 1.27 (m, 1H), 1.24 – 1.17 (m, 2H), 1.11 (d, J = 6.7 Hz, 3H), 1.08 – 1.03 (m, 
1H), 0.98 – 0.93 (m, 1H), 0.82 (dd, J = 6.6, 1.0 Hz, 3H). 13C NMR (150 MHz, C6D6): δ 
[ppm] = 152.1, 148.0, 136.1, 128.3, 122.1, 119.2 (q, J = 320.8 Hz, CF3), 52.6, 44.3, 44.3, 
44.1, 42.2, 38.0, 33.8, 29.7, 29.5, 28.0, 21.7, 21.5. Signal for C-OTf not observed. These 
findings are in accordance with the characterization of similar molecules. (Liu, L.-Z.; Han, 






To a degassed solution of 123 (20 mg, 49.5 µmol) and Pd(PPh3)4 (5.7 mg, 4.95 µmol) in 
THF (7 mL) at room temperature was added Me2Zn (1.2 M in toluene, 0.12 mL, 148 µmol) 
















aqueous NH4Cl solution (3 mL) was added. After extraction with Et2O (3 ´ 10 mL), the 
combined organic phases were dried over Na2SO4 and concentrated. The residue was 
purified by flash column chromatography (1% EtOAc/hexanes) to afford 10 mg (37.0 µmol, 
75%) of 124 as a colorless oil. 
TLC: Rf = 0.87 (2% EtOAc/hexanes). 1H NMR (400 MHz, C6D6): δ [ppm] = 7.13 (d, J = 
1.8 Hz, 1H), 5.22 – 5.19 (m, 1H), 2.69 – 2.62 (m, 1H), 2.60 – 2.52 (m, 1H), 2.46 – 2.38 (m, 
1H), 2.33 (d, J = 15.9 Hz, 1H), 2.07 – 1.98 (m, 1H), 1.85 – 1.91 (m, 1H), 1.81 – 1.74 (m, 
1H), 1.66 (d, J = 0.6 Hz, 3H), 1.62 – 1.56 (m, 4H), 1.50 – 1.39 (m, 2H), 1.22 – 1.00 (m, 
5H), 0.94 (d, J = 6.6 Hz, 3H). 13C NMR (151 MHz, CDCl3): δ [ppm] = 154.9, 137.4, 135.1, 
129.2, 127.8, 117.6, 56.6, 49.9, 45.8, 44.6, 43.5, 37.6, 33.8, 29.8, 29.6, 27.9, 21.8, 21.7, 

































































































































































































6.2. Total Synthesis of Sandresolide B and Amphilectolide 
 
Reprinted with permission from: 
I. T. Chen, I. Baitinger, L. Schreyer, D. Trauner, Org. Lett. 2014, 16, 166–169. 
 
Copyright© 2014 American Chemical Society. 
 
Author contribution statement 
I.B. optimized the reactions for the total synthesis of sandresolide B for compounds 7, 9, 
10, 12, 13, 14, 21, 22, 23 and 24, the results being documented in the supporting infor-
mation. I.B. developed conditions for the final reaction sequence leading to the formation 
of sandresolide B and characterized this molecule. I.B. has written a part of the manuscript 




























































































































































































































1. Introduction, Isolation and Structure  
Fungi of the genus Trichoderma have, in addition to potent cellulase activity,1 an array of 
bioactive chemical compounds.2 
 
Upon searching for bioactive metabolites in T. reesei, Pei and co-workers reported the 
isolation of trichodermatide A (127) in 2008 (Figure 3.1).3 The compound was extracted 
from T. reesei, which was collected from marine mud in the tideland of Lianyungang, China. 
Structural assignment was achieved by 1D and 2D NMR spectroscopy, mass spectroscopy 
and CD spectral analysis. 
 
 
Figure 3.1. Structure of trichodermatide A as proposed in 2008 
 
Trichodermatide A (127) is an unprecedented polyketide featuring a ketal-containing 
skeleton. Structural features of trichodermatide A (127) include an α-hydroxy vinylogous 
ester as well as a hexyl chain. The molecule contains eight stereogenic centers, seven of 
which are contiguous.  
 
In terms of its biological properties, trichodermatide A (127) exhibits weak cytotoxicity 
against the A375-S2 melanoma cell line with an IC50 value of 102.2 µg/mL.3 
 
Along with trichodermatide A (127), three other structurally related compounds, trichoder-
matide B–D (128–130), were isolated. In 2018, two further congeners, trichodermatide E 
(131) and F (132), have been found in T. applanatum (Figure 3.2).4 All members of the 
trichodermatide family carry the structural element of a cyclohexenone ring, fused to a 













Figure 3.2. Structures of trichodermatide B–F  
 
 
2. Proposed Biosynthesis 
Based on biosynthetic pathways of similar octaketides isolated from fungal sources,5,6 Pei 
and co-workers postulated a biosynthetic origin of trichodermatide A–D (127–130).3 That 
trichodermatide A (127) is composed of 22 carbon atoms, while only 16 carbon atoms are 
present in the structures of trichodermatide B–D (128–130), points toward diverging bio-
synthetic pathways.  
 
For the 16-carbon members of the family, the starting point of the hypothesized biosynthesis 
is the linear 16 carbon atom chain conjugated to coenzyme A (133), which proceeds to form 
the first ring through a Claisen condensation between C5 and C6 to give biosynthetic 
intermediate 134 (Scheme 3.1). This intermediate then undergoes a second cyclization 
through formation of a bond between C5 and C9 as well as reduction of the carbonyl groups, 
furnishing intermediate 135. Trichodermatide B (128), C (129) and D (130) are suggested 

































Scheme 3.1. Proposed biosynthesis of trichodermatide B–D 
 
For trichodermatide A (127, Scheme 3.2), the initial Claisen condensation of octaketide 133 
is also proposed to occur, followed by condensation with an additional triketide unit to form 
intermediate 138. Reduction of the carbonyl groups, and ring closure through bond 
formation between C1’ and C1 would then furnish tricyclic structure 139. Following 
hydroxylation, the vicinal diol at C9/C10 would cyclize onto the carbonyl at C5, resulting 










































Scheme 3.2. Proposed biosynthesis of trichodermatide A 
 
 
3. Structurally Related Natural Products 
The koninginins7-18 are the largest class of known structural relatives of the trichoder-
matides. With the exception of few members of the koninginin family (koninginin A (140), 
C (142), G (146), N (153) and O (154)), the main structural element found in this class is 
the α,β-unsaturated cyclohexenone fused to a pyran ring yielding the characteristic 
vinylogous ester moiety present in all trichodermatides. The koninginins commonly feature 
a linear six carbon atom chain (Figure 3.3). 
 
In addition to the above-described moieties, the following oxidation patterns are prevalent 
in the koninginins: the central cyclohexane is hydroxylated either at C2 or C4, C10 is often 
hydroxylated, and the C7 position can occasionally be hydroxylated. 
 
Notable variations of the koninginin structures include the reduction of the cyclohexenone, 
as present in koninginin A (140), C (142) and G (146), as well as replacement of the pyran 
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Not surprisingly, the koninginins were also isolated from Trichoderma species. Fungi of 
this genus are reported to be involved in biological control of antagonistic 
microorganisms19-21 and benefiting plant growth.22 Consequently, the search for metabolites 
with agrochemical potential has been the driver behind continuous investigations. 
Koninginin A–E (140–144)7-11 were initially found in the endophytic fungus T. koningii. 
All representatives inhibit the growth of etiolated wheat coleoptiles, like the congener 
koninginin G (146)13 from T. aureovide. Koninginin I (148), J (149) and K (150) have been 
isolated from T. neokoningii but were found not effective in assays for nematicidal 
activity.15 In 2015, koninginin L (151) and M (152) have been reported after isolation from 
T. koningii and their absolute configuration determined by x-ray analysis.16 Related 
compounds, koninginin N–Q (153–156), were isolated from T. koningiopsis and have 
demonstrated weak antifungal activity with MIC of 128 µg/mL (nyrstatin with MIC of 32 
µg/mL).17 Moderate antifungal activity has also been demonstrated by koninginin R (157) 
and S (158), which have been isolated from T. koningiopsis.18 As notable bioactivities, the 
koninginins E (144) and F (145) were found to inhibit effectively phospholipase A2 as well 
as inhibiting edema-inducing, myotoxic as well as enzymatic activities of the total venom 
of the jararacussu snake.12 
 
The trichodermaketones are one further, albeit relatively small, family of structural relatives 
to the trichodermatides. Following screening a library of marine microbial extracts for 
biological activity, compounds 159–162 were isolated from T. koningii (Figure 3.4). Of the 
isolated compounds, a biological effect was only found for trichodermaketone A (159), 
which showed synergistic antifungal activity with ketoconazole.23  
 
 





















trichodermaketone A (159) trichodermaketone B (160)
trichodermaketone C (161) trichodermaketone D (162)
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All trichodermaketones feature a tetrahydrobenzofurano-4-one structural motif, which 
Zhang and co-workers proposed to be generated by different cyclases compared to those 
involved in the biosynthesis of the trichodermatides.23 The trichodermaketones A (159) and 




4. Total Syntheses of the Trichodermatides 
The trichodermatides have attracted interest as a target to explore methodologies for 
selective installation of the respective oxygenated structures. Hsung and co-workers 
accessed the proposed structure of trichodermatides B (128) and C (129), but found 
deviations in the 1H and 13C NMR spectroscopic data of their synthesized material in 
comparison to the reported data.24 With regards to trichodermatide A (127), the Hiroya 
group has initially reported the total synthesis in 2013 with spectroscopic data identical to 
the natural product.25 The results reported by our group26 caused Hiroya and co-workers to 
initiate a structural reevaluation of trichodermatide A (127), leading to them proposing 
revised structure 167 of trichodermatide A in 201527 (Figure 3.5). Based on an analogous 
system bearing a shortened alkyl chain to facilitate crystallization, the group concluded the 
alternative structure was a C10 epimer of the originally reported configuration. In the 
synthesis of Hiroya and co-workers, ketone 163 was subjected to α-hydroxylation through 
generation of the enolate and treatment with Davis’ oxaziridine (Scheme 3.3). 
Nitrobenzoylation allowed for x-ray analysis, confirming the formation of the desired 
diastereomer 164. Reaction of 164 with SeO2 proceeded with an allylic oxidation to give 
alcohol 165, which underwent selective hydration to hemiacetal 166 in 83% yield. The 
structure could be confirmed by x-ray analysis before removal of the nitrobenzoate.  
 
 

























    Davis' oxaziridine
2. PNBzCl, NEt3
SeO2
1. Co(acac)2, PhSiH3, 
    O2, CF3CH2OH
2. K2CO3, MeOH
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Hiroya and co-workers concluded that the functionalization of the original synthetic 
trichodermatide A was identical to the analog with the shortened alkyl chain and therefore 
proposed structure 167 for trichodermatide A (Figure 3.5). Further support of their findings 
was provided by NOESY experiments of their synthetic trichodermatide A (167), showing 
correlations between H10 and C9-OH, while 1H and 13C NMR spectra were identical to 
those reported for the isolated material.27 
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5.1. Total Synthesis of the Proposed Structure of Trichodermatide A  
 
Reprinted with permission from: 
E. Myers, E. Herrero-Gómez, I. Albrecht, J. Lachs, P. Mayer, M. Hanni, C. Ochsenfeld, 
D. Trauner, J. Org. Chem. 2014, 79, 9812–9817. 
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atm standard atmosphere (1.01325 bar) 
b broad 
B3LYP Becke, three-parameter, Lee-Yang-Parr 




CAM ceric ammonium nitrate 
cat. catalytic 
CD circular dichroism 
CoA coenzyme A 
cont. continued 
m-CPBA meta-chloroperoxybenzoic acid  
CSA camphorsulfonic acid 
d doublet 
DBU 1,8-diazabicyclo[5.4.0]undec-7-ene 
DCM dichloromethane  





DMP Dess–Martin periodinane  
DMPU 1,3-dimethyltetrahydropyrimidin-2(1H)-one  
DMSO dimethyl sulfoxide 
DNB 2,4-dinitrobenzyl 
DTBP di-tert-butyl peroxide 
EDCl 1-ethyl-3-[3-(dimethylamino)propyl]carbodiimide  
EI electron ionization 
ESI electrospray ionization 
 250
Et ethyl 
FTIR fourier-transform infrared spectroscopy 
GGPP geranylgeranyl pyrophosphate 
hn ultraviolet irradiation  
HF Hartree-Fock 
HMBC heteronuclear multiple bond correlation experiment 
HPLC high performance liquid chromatography 
HRMS high resolution mass spectrometry  
KHMDS potassium hexamethyldisilazide  
HSQC heteronuclear single quantum correlation experiment 
HWE Horner–Wadsworth–Emmons 
IMDA intramolecular Diels–Alder 
IR infrared spectroscopy 
LDA lithium diisopropylamide 
m multiplet 
MIC minimum inhibitory concentration 
m.p. melting point 
Me methyl 
MOM methoxy methyl ether 
MS mass spectrometry  
MsOH methanesulfonic acid  
MP2 second-order Møller–Plesset perturbation theory 
NaHMDS sodium hexamethyldisilazide 
NMO N-methylmorpholine N-oxide 
NMR nuclear magnetic resonance 
NOE nuclear Overhauser effect 
NOESY nuclear Overhauser effect spectroscopy 
[O] oxidant 
OPLS optimized potential for liquid simulations 
PCC pyridinium chlorochromate  
Ph phenyl 
pKa logarithmic acid dissociation constant 




PNBzCl p-nitrobenzoyl chloride 
ppm parts per million 
i-Pr isopropyl 
PTSA p-toluenesulfonic acid 
Py pyridine 
q quartet 
RI resolution-of-the-identity  
Rf retention factor 
s singlet  
SVP split valence polarization 
t triplet 
TBAF tetra-n-butylammonium fluoride 
TBS tert-butyldimethysilyl 
TEA triethylamine 
TES triethylsilyl  
Tf trifluoromethanesulfonate 
TFA trifluoroacetic acid 
TFAA trifluoroacetic anhydride 
THF tetrahydrofuran 
TLC thin layer chromatography 
TMS trimethylsilyl 
TMSCl trimethylsilyl chloride 
TMSCN trimethylsilyl cyanide 
TPAP tetrapropylammonium perruthenate 
Ts p-toluenesulfonyl  
TZVP valence triple-zeta polarization 
Wnt wingless/integrated 
 
 
 
